Halozyme Therapeutics, Inc.
USD66.28
-1.86 (-2.73%)
CEO
Helen I. Torley
IPO Date
2004-03-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$67.38
Prev. Close
$68.14
Day Low
$65.59
Day High
$67.44
52W Low
$51.06
52W High
$82.22
Market Cap
$7.86B
Volume
1.74M
| 9,725 |
| $64.63 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 3,575 | $65.46 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 6,700 | $66.33 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 100 | $67.85 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 1,398 | $70.29 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 9,802 | $71.37 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 5,900 | $72.15 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | S-Sale | Disposed | 2,800 | $73.12 |
| 13 May 2026 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | Acquired | 10,000 | $12.07 |
| Type |
|---|
| Amount |
|---|
| 8 Apr 2025 | Gilbert Cisneros | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 4 Oct 2024 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 13 Aug 2023 | Daniel Goldman | Daniel Goldman | Sale | $15,001 - $50,000 |
| 13 Jan 2023 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 16 Sept 2022 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 20 Sept 2021 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 5 Nov 2020 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 5 Nov 2020 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |